Project Number 2021DH Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2021 View Full Project Details for Understanding the effect of apoE on tau-mediated neurodegeneration Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 4. ApoE and Lipid Neurobiology b. ApoE in AD Pathogenesis Independent of Abeta Researcher and Organization Principal Investigator Holtzman, David Principal Investigator First Name David Principal Investigator Last Name Holtzman Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement 2021 Research Grants FY Overall Cost $300,000 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States Program Official CureAlzFund
